In my opinion galidisivir is the more attractive opportunity. Of course the best outcome would be a successful ISLA-101 trial and purchasing galidisivir, but if I had to choose only one I would choose galidisivir. Being able to gain FDA approval with just an animal study is very, very attractive.
In my opinion galidisivir is the more attractive opportunity. Of...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
-0.005(3.57%) |
Mkt cap ! $31.87M | |||
| Open | High | Low | Value | Volume |
| 14.0¢ | 14.0¢ | 13.5¢ | $4.81K | 34.77K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6644 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 56381 | 2 |
View Market Depth
| Last trade - 11.04am 24/06/2025 (20 minute delay) ? |
| ILA (ASX) Chart |